跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
STREPSILS MAX PLUS LOZENGES - HSA Drug Approval Details
Approvals
/
HSA
/
STREPSILS MAX PLUS LOZENGES
Approved
THERAPEUTIC
STREPSILS MAX PLUS LOZENGES
RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED - UNITED KINGDOMRECKITT BENCKISER HEALTHCARE MANUFACTURING (THAILAND) LTD (THAILAND)
🇸🇬 Health Sciences Authority
Approval Date
Jul 11, 1996
Approval ID
402a09f6065f785e
Company
RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED - UNITED KINGDOMRECKITT BENCKISER HEALTHCARE MANUFACTURING (THAILAND) LTD (THAILAND)
Type
Therapeutic
Approval Details
Approval Id
402a09f6065f785e
Drug Name
STREPSILS MAX PLUS LOZENGES
Product Name
STREPSILS MAX PLUS LOZENGES
Approval Number
SIN08806P
Approval Date
1996-07-11
Registrant
RECKITT BENCKISER (SINGAPORE) PTE LTD
Licence Holder
RECKITT BENCKISER (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
LOZENGE
Route Of Administration
ORAL
Atc Code
R02AA03
Atc Item Name
dichlorobenzyl alcohol
Pharma Manufacturer Name
RECKITT BENCKISER (SINGAPORE) PTE LTD
Active Ingredients
AMYLMETACRESOL
0.6 mg
DICHLOROPHENYLCARBINOL
1.2 mg
LIGNOCAINE HCl
10 mg
AMYLMETACRESOL
0.6 mg
DICHLOROPHENYLCARBINOL
1.2 mg
LIGNOCAINE HCl
10 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 11, 1996
Approval ID
402a09f6065f785e
Type
Therapeutic
Back to HSA Approvals